Induction chemotherapy with epirubicin and cisplatin in patients with locally advanced undifferentiated nasopharyngeal carcinoma

被引:0
|
作者
Yamouni, M [1 ]
Benhadji, KA [1 ]
Beldjillati, Y [1 ]
Lahfa, I [1 ]
Djellali, L [1 ]
机构
[1] CHU Oran, Dept Med Oncol, Oran, Algeria
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S84 / S84
页数:1
相关论文
共 50 条
  • [31] Cisplatin and Fluorouracil induction Chemotherapy With or Without Docetaxel in Locoregionally Advanced Nasopharyngeal Carcinoma
    Jin, Ting
    Qin, Wei-feng
    Jiang, Feng
    Jin, Qi-feng
    Wei, Qi-chun
    Jia, Yong-shi
    Sun, Xiao-nan
    Li, Wen-feng
    Chen, Xiao-zhong
    TRANSLATIONAL ONCOLOGY, 2019, 12 (04): : 633 - 639
  • [32] Induction chemotherapy for the treatment of non-endemic locally advanced nasopharyngeal carcinoma
    Zhao, Lina
    Xu, Man
    Jiang, Wen
    Pan, Haitao
    Zang, Jian
    Luo, Shanquan
    Wang, Jianhua
    Zhou, Yongchun
    Shi, Mei
    ONCOTARGET, 2017, 8 (04) : 6763 - 6774
  • [33] Assessment of Response to Different Induction Chemotherapy Regimens in Locally Advanced Nasopharyngeal Carcinoma
    Lian, Chen-Lu
    Zhou, Rui
    Zhou, Yuan
    Zhou, Ping
    Wu, San-Gang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 551 - 562
  • [34] Induction chemotherapy with cysplatin and epirubicin followed by radiotherapy and concurrent cysplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population
    Airoldi, M.
    Garzaro, M.
    Raimondo, L.
    Gabriele, A. M.
    Giordano, C.
    EJC SUPPLEMENTS, 2009, 7 (02): : 486 - 486
  • [35] Efficacy of nimotuzumab added to concurrent chemoradiotherapy after induction chemotherapy for patients with locally advanced nasopharyngeal carcinoma
    Wu, Sangang
    Wang, Runjie
    Yu, Yifeng
    Zhou, Ping
    Lian, Chenlu
    Wang, Jun
    Lin, Qin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [36] Comparison of induction chemotherapy plus concurrent chemoradiotherapy and induction chemotherapy plus radiotherapy in locally advanced nasopharyngeal carcinoma
    Wang, Qiaoli
    Xu, Guoqiang
    Xia, Yaoxiong
    Zuo, Jia
    Zeng, Guilin
    Xue, Zhihong
    Cao, Ruixue
    Xiong, Wei
    Li, Wenhui
    ORAL ONCOLOGY, 2020, 111
  • [37] CHEMOTHERAPY OF METASTATIC AND OR RECURRENT UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA WITH CISPLATIN, BLEOMYCIN, AND FLUOROURACIL
    BOUSSEN, H
    CVITKOVIC, E
    WENDLING, JL
    AZLI, N
    BACHOUCHI, M
    MAHJOUBI, R
    KALIFA, C
    WIBAULT, P
    SCHWAAB, G
    ARMAND, JP
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (09) : 1675 - 1681
  • [38] Ifosfamide/cisplatin-based chemotherapy in metastatic undifferentiated nasopharyngeal carcinoma
    Stein, ME
    Drumea, K
    LARYNGOSCOPE, 1997, 107 (11): : 1559 - 1559
  • [39] Neoadjuvant Chemotherapy Improves Survival in Patients with Locally Advanced Nasopharyngeal Carcinoma
    Basaran, Hamit
    Cengiz, Mustafa
    Yazici, Gozde
    Susulu, Nilda
    Aksoy, Sercan
    Hosal, Ali Sefik
    Gullu, Ibrahim H.
    Ozyigit, Gokhan
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2019, 29 (03): : 176 - 185
  • [40] Induction chemotherapy followed by alternating chemo-radiotherapy in advanced undifferentiated nasopharyngeal carcinoma (UNPC)
    Ponzanelli, A.
    Benasso, M.
    Vigo, V.
    Bacigalupo, A.
    Marcenaro, M.
    Rosso, R.
    ANNALS OF ONCOLOGY, 2006, 17 : XI86 - XI86